Toggle navigation
About
Approach
Team
Companies
News Room
Contact
Granular Therapeutics to accelerate development of next-generation pipeline for treating mast cell driven diseases
Press Release
Aldena Therapeutics Accelerates its Novel and Disruptive Approach to Immuno-Dermatology
Press Release
Incyte Announces Agreement to Acquire Medicxi-backed Villaris Therapeutics and Auremolimab (VM6), an Anti-IL-15Rβ Monoclonal Antibody
Press Release
Medicxi portfolio company MiroBio to be acquired by Gilead Sciences for approximately $405 million
Press Release
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ TRIPLE PAK™ (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA™ DUAL PAK™ (vonoprazan, amoxicillin)
Press Release
Rivus Pharmaceuticals Announces Positive Data from Phase 2a Clinical Trial of Lead Candidate HU6, Demonstrating Fat Reduction and Weight Loss in High BMI Participants
Press Release
